NASDAQ: AZRX

SEARCH

SIGN UP

Menu

Investor Relations

AzurRx BioPharma is a development stage biopharmaceutical company (NASDAQ: AZRX) focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome related conditions. 

Stock Quote - AzurRx (NASDAQ: AZRX)

*Delayed quote courtesy of Google.

Stock Chart

sdf

sdf

sdf

sdf

Recent Press Releases

Date Title
07 May, 2020 AzurRx BioPharma Announces Entry into Packaging, Labeling and Distribution Agreement with Creapharm Clinical Supplies for MS1819 Clinical Trial Drug Product
05 May, 2020 AzurRx BioPharma Receives Approximately $721,000 for its 2019 CIR (French Research Tax Credit)
30 Apr, 2020 AzurRx BioPharma Receives Insititutional Review Board Approval to Commence its Phase 2 OPTION 2 Clinical Trial of MS1819 in Cystic Fibrosis